BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19069310)

  • 1. Catabolic mediators of cancer cachexia.
    Tisdale MJ
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):256-61. PubMed ID: 19069310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
    Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α and cancer cachexia: Molecular insights and clinical implications.
    Patel HJ; Patel BM
    Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic and local mechanisms leading to cachexia in cancer].
    Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).
    Mirza KA; Wyke SM; Tisdale MJ
    Br J Cancer; 2011 Jun; 105(1):83-8. PubMed ID: 21673682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of skeletal muscle in cancer: biochemical mechanisms.
    Tisdale MJ
    Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation.
    Eley HL; Tisdale MJ
    J Biol Chem; 2007 Mar; 282(10):7087-97. PubMed ID: 17213191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.
    Mirza KA; Luo M; Pereira S; Voss A; Das T; Tisdale MJ
    In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):838-45. PubMed ID: 27194344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle.
    Todorov PT; Wyke SM; Tisdale MJ
    Cancer Res; 2007 Dec; 67(23):11419-27. PubMed ID: 18056470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
    Russell ST; Eley H; Tisdale MJ
    Cell Signal; 2007 Aug; 19(8):1797-806. PubMed ID: 17532611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
    Wyke SM; Russell ST; Tisdale MJ
    Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cachexia.
    Tisdale MJ
    Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysis.
    Kamoshida S; Watanabe K; Suzuki M; Mizutani Y; Sakamoto K; Sugimoto Y; Oka T; Fukushima M; Tsutsumi Y
    Biomed Res; 2006 Dec; 27(6):275-81. PubMed ID: 17213683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.
    Mirza KA; Tisdale MJ
    Cell Signal; 2012 Nov; 24(11):2118-22. PubMed ID: 22820507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.